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Background: Intracranial aneurysm (IA) is often asymptomatic until the time of rupture resulting in subarachnoid
hemorrhage (SAH).There is no precise biochemical or phenotype marker for diagnosis of aneurysm. Environmental
risk factors that associate with IA can result in modifying the effect of inherited genetic factors and thereby increase
the susceptibility to SAH. In addition subsequent to aneurismal rupture, the nature and quantum of inflammatory
response might be critical for repair. Therefore, genetic liability to inflammatory response caused by polymorphisms
in cytokine genes might be the common denominator for gene and environment in the development of aneurysm
and complications associated with rupture.
Methods: Functionally relevant polymorphisms in the pro- and anti-inflammatory cytokine genes IL-1 complex
(IL1A, IL1B, and IL1RN), TNFA, IFNG, IL3, IL6, IL12B, IL1RN, TGFB1, IL4, and IL10] were screened in radiologically confirmed
220 IA patients and 250 controls from genetically stratified Malayalam-speaking Dravidian ethnic population of
south India. Subgroup analyses with genetic and environmental variables were also carried out.
Results: Pro-inflammatory cytokines TNFA rs361525, IFNG rs2069718, and anti-inflammatory cytokine IL10 rs1800871
and rs1800872 were found to be significantly associated with IA, independent of epidemiological factors. TGFB1
rs1800469 polymorphism was observed to be associated with IA through co-modifying factors such as hypertension
and gender. Functional prediction of all the associated SNPs of TNFA, IL10, and TGFB1 indicates their potential role in
transcriptional regulation. Meta-analysis further reiterates that IL1 gene cluster and IL6 were not associated with IA.
Conclusions: The study suggests that chronic exposure to inflammatory response mediated by genetic variants in
pro-inflammatory cytokines TNFA and IFNG could be a primary event, while stochastic regulation of IL10 and
TGFB1 response mediated by comorbid factors such as hypertension may augment the pathogenesis of IA
through vascular matrix degradation. The implication and interaction of these genetic variants under a specific
environmental background will help us identify the resultant phenotypic variation in the pathogenesis of intracranial
aneurysm. Identifying genetic risk factors for inflammation might also help in understanding and addressing the
posttraumatic complications following the aneurismal rupture.
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Intracranial aneurysm (IA) is often asymptomatic until
the time of rupture resulting in subarachnoid hemorrhage
(SAH).There is no precise biochemical or phenotype
marker for diagnosis of aneurysm. Rupture of cerebral
aneurysm is the foremost cause for spontaneous
subarachnoid hemorrhage (SAH). Intracranial aneurysm
accounts for 85 % of subarachnoid hemorrhage (SAH),
which contributes for 5–15 % of strokes [1] but occurs at
a fairly young age and accounts for 25 % of stroke-related
mortality [2]. In an earlier study, we have reported that
hypertension and smoking are causal risk factors which
might also modify the effect of genetic factors resulting in
increased susceptibility to aSAH in the Indian population
[3]. Inherited and acquired risk factors indicate influence
on hemodynamic factors, defects in the vessel wall which
may be in the muscular layer (tunica muscularis) of arter-
ies, or alterations in the internal elastic membrane (lamina
elastica interna) of cerebral arteries [4]. It is believed that
hemodynamic stress can trigger localized inflammatory
infiltration leading to formation of intracranial aneurysm
by thinning and weakening in intracranial vessel [5]. Stud-
ies have pointed towards the presence of inflammatory
cells such as macrophages, T and B lymphocytes in the
wall of intracranial arteries [6].Various expression studies
carried out till date with respect to intracranial aneurysm,
support the role of inflammation and immune response
with intracranial aneurysm [7]. These reports clearly dem-
onstrate that inflammation plays a pivotal role in the
pathogenesis of intracranial aneurysm.
Inflammation is an essential component of the immune
response which involves inflammatory factors such as
cytokines. When endothelial cells undergo inflammatory
activation, it recruits cytokines, growth factors, and
matrix metalloproteinase’s (MMPs). Balance between
pro-inflammatory and anti-inflammatory cytokines defines
the control of inflammation [8]. If vascular inflammation
progresses unresolved, it can lead to vascular disease,
whereas delayed inflammatory response can lead to ECM
deposition, granular tissue formation and connective tis-
sue growth. One would presume that genetic variability in
cytokine genes can result in differential activation of im-
mune response. The present study intends to explore the
genetic role of pro-inflammatory and anti-inflammatory
cytokine genes in intracranial aneurysm in a south Indian
population. The study intends to evaluate the functionally
relevant polymorphic variants of pro-inflammatory and anti-
inflammatory cytokine genes [IL-1 complex (IL1A, IL1B,
and IL1RN), TNFA, IFNG, IL3, IL6, IL12B, IL1RN, TGFB1,
IL4, and IL10] and their role in aSAH. The role of these
cytokine variants in influencing the epidemiological risk
factors such as hypertension, gender and smoking and its
relevance in global perspective will also be examined in
the present study.Materials and methods
Study population
The study populations consist of radiologically confirmed
220 IA cases and 250 ethnically and age-matched controls
from the Malayalam-speaking Dravidian ethnic population
of south India. The study was restricted to Malayalam-
speaking Dravidian ethnic population of south India to
avoid population stratification issues [9]. Patients having
saccular intracranial aneurysm with aSAH were initially
screened by CT and were angiographically confirmed
by magnetic resonance angiography (MRA) and digital
subtraction angiography (DSA). Exclusion criteria in-
clude patient with non-saccular aneurysm, arteriovenous
malformation (AVMs), and other hereditary connective
tissue disorders like autosomal dominant polycystic kidney
disease, Marfan syndrome, and Ehlers-Danlos syndrome.
Cases were recruited from two main tertiary care
neurosurgical centers in Kerala. All the patients were rated
based on WFNS scale. The control population consists of
age-, sex-, and ethnicity-matched individuals who were
symptomatically normal and did not possess any symp-
toms or family history of intracranial aneurysm. All the
study subjects gave informed, written consent in a stand-
ard consent form to participate in the study after being
provided with and receiving a full explanation of study
protocols and objectives. The present study was approved
by the institutional ethics committee of Rajiv Gandhi Center
for Biotechnology, established as per the Indian council of
medical research guidelines. Peripheral blood was collected
from the study subjects in EDTA-coated vials, and DNA
was isolated by conventional phenol-chloroform method.
SNP selection and genotyping
SNPs were selected based on the functional relevance and
minor allele frequency using genotype data obtained from
Caucasian individuals in the HapMap project (HapMap
Data Rel 24/Phase II Nov08, on NCBI B36 assembly,
dbSNP b126). Some of the SNPs of IL6, IL12B, IL1A, and
IL1B were selected based on their associations in the pre-
vious studies. Genotyping of 22 SNPs from (IL1A, IL1B,
and IL1RN), TNFA, IFNG, IL3, IL6, IL12B, IL1RN, TGFB1,
IL4, and IL10 was carried out using TaqMan allelic dis-
crimination assays (Applied Biosystems, Foster City, CA,
USA) and KASPar method (KBioscience, Hoddesdon, UK)
(Additional file 1: Table S1). TaqMan and KASPar reactions
were performed in a 5-μl volume according to the man-
ufacturer’s instructions on a 384-well-based ABI7900HT
thermo cycler. Detection was performed using an ABI
PRISM 7900 HT sequence detection system with SDS 2.4
software (Applied Biosystems, Foster City, CA, USA).
Statistical analysis
Genotype and allelic frequencies were computed and were
tested for deviation from Hardy-Weinberg equilibrium
Table 1 Clinical characteristics of patients
Patient characteristics
Mean age ± SD, years 51.17 ± 11.37
Men, % 55.7
Women, % 44.2
History of hypertension,% 35
History of diabetes, % 5.4
Family history of aSAH, % 3.7
Cigarette smoking, % 42.92
Alcohol use, % 21.8
Intracranial aneurysm location Percentage
Anterior communicating artery 39.21
Anterior cerebral artery 8.37
Middle cerebral arteries 22.91
Internal carotid artery 17.18
Posterior communicating artery 8.81
Basilar artery 2.64
Posterior cerebral artery 0.44
Vertebral arteries 0.44
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statistical analyses were performed using the GraphPad
Prism 5.01, San Diego, CA, USA. We considered p value
of <0.05 as significant. Chi-square test, allelic odds ratios
(OR), and 95 % confidence intervals (CI) were calculated
by Fisher’s exact test (two-tailed). To estimate linkage dis-
equilibrium (LD) between pairs of loci in the patient and
control populations, standardized disequilibrium coeffi-
cient (D′) and squared correlation coefficient (r2) were
calculated using Haploview 4.1 (www.broad.mit.edu/mpg/
haploview/). LD blocks were defined in accordance with
Gabriel’s criteria. Further stratification of the patients was
done to understand the role of associated cytokine gene
variant between genders and hypertensive and non-
hypertensive groups.
Functional prediction of the deleterious effect if any of
the associated SNPs with respect to the functional categor-
ies such as protein coding, splicing regulation, transcrip-
tional regulation, and post-translation was assessed in
silico using F-SNP program (compbio.cs.queensu.ca/F-
SNP/), FastSNP (fastsnp.ibms.sinica.edu.tw), SNPNexus
(snpnexus.org), HaploReg (broadinstitute.org/mammals/
haploreg), and regulomeDB (regulome.stanford.edu). F-
SNP extracts information from large number of resources
such as PolyPhen, SIFT, SNPeffect, SNPs3D, LS-SNP,
Ensembl, ESEfinder, RescueESE, ESRSearch, PESX,
TFSearch, Consite, GoldenPath, KinasePhos, OGPET, and
Sulfinator to generate a functional significance (FS) score.
A meta-analysis with the random effects and fixed ef-
fects model was performed for previously studied SNPs
using Review Manager 5.2 (reviewmanager.software.
informer.com/5.2/). All the previous studies which ex-
plored similar variants in genes involved in inflamma-
tory and anti-inflammatory cytokines were included in
this study. The meta-analysis included the most studied
SNPs in immune response, rs1800796 of IL6 [10–14],
rs3212227 of IL12B [15], and rs16944 of IL1B [16, 17]
(Additional file 1: Table S2). The inconsistency index I2
was used to assess between-study heterogeneity. A p
value of <0.05 was considered as significant throughout
the analyses.
Results
The demographic and clinical characteristics of subjects
were recorded and are summarized in Table 1. All the
studied variants were in Hardy-Weinberg equilibrium
(p > 0.05) in healthy controls. Using a case control design,
we observed a novel association with pro-inflammatory cy-
tokines TNFA and IFNG (Table 2, Fig. 1). In TNFA
rs361525 was found to be associated with IA at allelic (p =
0.019, OR 1.89, CI 1.16 to 3.06) and genotypic level (p =
0.010). In case of IFNG, of the two variants screened
(rs2069718 and rs2430561), a genotypic association was
observed for rs2069718 (p = 0.020). However, some of theextensively studied pro-inflammatory cytokine variants
such as rs1800587of IL1A and rs1143627 and rs16944 of
IL1B in IL1 gene cluster were not found to be associated
with IA in south Indian population (Additional file 1: Table
S3). Similarly with IL6 variants too, we could not observe a
major significant association although IL6 variants
rs1800796 (−572C/G) indicated a trend towards associ-
ation (Table 2) with IA in the present study population.
The SNPs in pleiotropic cytokine genes IL3, IL12B, IL4,
and anti-inflammatory gene TGFB1 were also not found to
be associated with intracranial aneurysm (Additional file 1:
Table S3). However, two linked SNPs of anti-inflammatory
cytokine IL10 rs1800871 and rs1800872 indicated an asso-
ciation with heterozygous genotype with p value of 0.016
and 0.005, respectively, with IA (Table 2).The frequency of
these variants vary widely across different world popula-
tion. In silico functional prediction results for all the asso-
ciated SNPs indicate that TNFA rs361525 and IL10
rs1800871 and rs1800872 have potential role in transcrip-
tional regulation (Table 2, Additional file 1: Table S4).
Stratification of data based on hypertension and gender
was further carried out within the patient group to identify
whether genetic association for IA was influenced by
hypertension or gender or independent of these factors.
We could not find any significant association for this
stratification analysis with exception to TGFB1 Arg25Pro
rs1800471. The SNPs that were associated with IA were
not influenced by genetic association of hypertension
(Fig. 2) or gender (Additional file 1: Figure S1). Interest-
ingly, in the subgroup analysis, TGFB1 rs1800471 which
Table 2 Comparison of the genotype and allele frequencies of associated cytokine gene variants between patients and controls
p value OR(95 %CI) p value FS score
IFNG AA AG GG A G
rs2069718 Cases 79 103 39 0.020 261 181 1.20 (0.926 to 1.560) 0.184 ND
0.36 0.47 0.18 0.59 0.41
Controls 61 143 39 265 221
0.25 0.59 0.16 0.55 0.45
TNF GG AG AA G A
rs361525 Cases 171 42 2 384 46 1.89 (1.163 to 3.064) 0.010 0.208
0.80 0.20 0.01 0.019 0.89 0.11
Controls 216 25 2 457 29
0.89 0.10 0.01 0.94 0.06
IL6 GG GC CC G C
rs1800796 Cases 57 126 37 0.050 240 200 0.94 (0.729 to 1.225) 0.691 0.208
0.26 0.57 0.17 0.55 0.45
Controls 81 111 52 273 215
0.33 0.45 0.21 0.56 0.44
IL10 CC CT TT C T
rs1800871 Cases 48 142 40 0.016 238 222 1.08 (0.837 to 1.396) 0.558 0.101
0.21 0.62 0.17 0.52 0.48
Controls 61 118 62 240 242
0.25 0.49 0.26 0.50 0.50
IL10 AA AC CC A C
rs1800872 Cases 39 143 48 0.005 221 239 0.955 (0.740 to 1.233) 0.745 0.101
0.17 0.62 0.21 0.48 0.52
Controls 62 116 66 240 248
0.25 0.48 0.27 0.49 0.51
FS score functional significance score, ND not determined
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sociated with hypertension-mediated resultant IA (Fig. 2).
Meta-analysis with the SNPs in the cytokine genes was
carried out with data from earlier studies and including
the present study. Meta-analysis with the promoter
polymorphism rs1800796 (−572C/G) of IL6 indicatedFig. 1 Genetic association analysis with studied variants between IA patienhigh heterogeneity between studies (I2 = 93 %) which ac-
counts for the large variation in different studies shown
by opposite alleles being associated in different world
population. This prompted us to carry out meta-analysis
using both random and fixed effect models. While com-
paring C versus G allele between IA patients and normalts and controls. SNPs were plotted against –log(p value)
Fig. 2 Genetic association analysis with studied variants between hypertensive and non-hypertensive IA. SNPs were plotted against –log(p value)
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fect model (Z = 3.57, p = 0.0004) while no association
was observed in random effect model (Z = 0.02, p = 0.98)
(Fig. 3). Further stratification of studies into two groups
was carried out based on the associated allele (group A:
C versus G allele in IA patients versus control in C
allele-associated population (Fig. 4) and group B: G ver-
sus C allele in IA patients versus control in C allele-
associated population) (Fig. 5). This was specifically
done as G allele was associated in Han Chinese ethnicity
while C allele was found to be associated in Caucasian
and Cantonese ethnicity. Association was observed with
both C allele (Z = 2.38, p = 0.02) and G allele (Z = 6.60,
p < 0.00001) with fixed effect model (Figs. 4 and 5). Meta-Fig. 3 Meta-analysis of IL6 rs1800796 (−572C/G) C versus G allele in patient
effect modelsanalysis with rs3212227 of IL12B and rs16944 of IL1B did
not show any association in both fixed effect and random
effect models (Figs. 6 and 7).
Discussion
The present study explores the genetic liability to in-
flammatory response induced by genetic variability in
cytokine genes and how this genetic variability through
differential inflammatory response could result in the
development of aneurysm. The study comprised of pro-
inflammatory cytokines IL1, IFNG, TNFA, and IL6; anti-
inflammatory cytokines IL1RN, TGFB1, and IL10; and
pleiotropic cytokines IL3, IL12B, and IL4 genes. We report
a novel association with pro-inflammatory cytokiness with intracranial aneurysm versus normal control. Random and fixed
Fig. 4 Meta-analysis of IL6 rs1800796 (−572C/G) C versus G allele in patients with intracranial aneurysm versus normal control in C allele-associated
population. Random and fixed effect models
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ciation with the pro-inflammatory cytokines of IL1 gene
cluster and IL6 were not found to be associated in the
present study. None of the pleiotropic cytokines were as-
sociated with IA in the present study, but we did observe
a novel association with anti-inflammatory cytokines IL10.
Most of the studies till date were restricted to individual
cytokines and mainly focused on IL1B, IL6, and TNFA
which could not be replicated in different ethnicities. WeFig. 5 Meta-analysis of IL6 rs1800796 (−572C/G) G versus C allele in patients w
population. Random and fixed effect modelscould not find any significant association for subgroup
analysis which suggests that the associated SNPs might
have a direct effect on the development of IA and was in-
dependent of hypertension and gender. Limitation of the
study was with large effect size, and this would involve in-
creased sample size. Large effect sizes are uncommon in
complex diseases and therefore multiple testing was not
applied to the study. Increasing sample size would mean
sampling genetically non-stratified sample which willith intracranial aneurysm versus normal control in C allele-associated
Fig. 6 Meta-analysis of IL12B gene variant rs3212227 with intracranial aneurysm. Random and fixed effect models
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son why genetic studies are not replicable across ethnici-
ties, and this conflict is evident in the meta-analysis due to
genetic heterogeneity. Monitoring the cytokine levels of
these associated cytokines might be of interest in IA
pathogenesis as the immunogenetic background might
suggest an individual’s response to a given immunological
stress in the development and progression of aneurysm.
The differential inflammatory response mediated byFig. 7 Meta-analysis of IL1B gene variant rs16944 with intracranial aneurysmgenetic variants in cytokines could be a primary event,
while inflammatory response mediated by pre- or post-
traumatic stress or comorbid factors could further aug-
ment the disease pathology.
Association with TNFA polymorphic variant in the
present study is interesting as it is known to be a power-
ful pro-inflammatory cytokine. Expression studies indi-
cate overexpression of TNFA to modulate susceptibility
to IA [18]. While IA is known to be a multifactorial. Random and fixed effect models
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TNF is also multistimulatory. Therefore, how TNFA pro-
motes pathogenesis of IA is indeed a challenge. In-Silico
functional prediction suggests that rs361525 variant is
involved in transcriptional regulation with FS score of
0.208. Functional studies with rs361525 show differential
effect of transcriptional activation with TNFA rs361525-
238A allele conferring increased transcriptional activa-
tion of the TNF promoter [19]. “A” allele of rs361525
has been reported to enhance the responsiveness of
TNFA promoter by 2.2 to 2.8 times greater versus the
“G” variant, when stimulated with pro-inflammatory
stimuli [19]. Functional validation studies further sug-
gests that “A” allele of rs361525 creates a functionally
active thyroid hormone receptor (TR) binding site which
resulted in TR-α-induced promoter overexpression by
1.8-fold. Earlier studies on TNFA provided evidence for
rs1800629 (−308 G<A) with IA in Italian population, but
this SNP was not found to be associated with our study
population [20]. It has been reported that among TNFA
promoter polymorphisms, rs361525 could modulate
transcriptional regulation but not the rs1800629 [21].
Therefore, association with “A” allele of rs361525 in the
present study could indicate overproduction of TNFα
as a genetic event and thereby mediating development
and rupture of IA in south Indian population. Risk fac-
tors that associate with intracranial aneurysm such as
hemodynamic stress [22], hypertension [23], and
smoking [24] are also known to induce the production
of TNFα. Increased stimulation of TNFα and Fas-
associated death domain protein, which are involved in
inflammation and apoptosis, can have deleterious ef-
fect on arterial wall [18]. Thus, in the present study,
the over representation of A allele which refers to in-
creased transcriptional activation of TNF promoter
may result in the development of aneurysm or aneur-
ismal rupture, through its multistimulatory role in-
duced by multifactorial nature of IA.
Genetic association of TNFA and IFNG may further
exacerbate the pro-inflammatory role as TNFA is known
to synergize with IFNG in inhibiting the proliferation of
various cell types. The growth inhibitory activities of
IFNG are more pronounced in endothelial cells. Poly-
morphisms in the promoter regions of IFNG have been
reported to influence IFN-γ production. In the present
study, we report higher representation of IFNG +3234TT
genotype in aneurismal patients. Based on the functional
studies of +3234C/T polymorphism, +3234C alleles has
been reported to be associated with a higher level of IFN-
γ than the +3234T alleles [25]. Higher frequency of homo-
zygous +3234TT genotype could be indicative of lower
levels of IFN-γ. The regulation of IFNG gene transcrip-
tion is complex and several transcription factors have
been found to interact with the proximal promoterconstitutively [26] or by induction [27]. One of the
most important functions of IFNG is macrophage acti-
vation function, which upregulates the expression of
the major histocompatibility complexes (MHC)I [28]
and MHCII [29], involved in antigen processing and
presentation pathways. IFN-γ also mediates functions
such as leukocyte attraction [28], maturation and differ-
entiation, natural killer (NK) cell activity [30], and im-
munoglobulin (Ig) production and class switching in B
cells [28].Therefore, reduced IFN-γ production would
result in compromised resultant functions such as re-
duced leukocyte attraction or macrophage activation.
Pro-inflammatory cytokines are linked in a sequence
resembling an electrical circuit in series, with TNF-α at
the apex of the cascade inducing production of IL-1,
and subsequently both TNF-α and IL-1 induce down-
stream cytokines such as IL-6 [31]. Polymorphisms in
any of these genes are likely to alter the downstream
functional events. Earlier studies did provide evidence
with contradictions for involvement of IL1 gene com-
plex with IA. A study in Polish population has reported
an association of IL1B rs16944 with IA, but this could
not be replicated in Italian population [16, 17]. IL1RN
VNTR polymorphism has been widely implicated in is-
chemic stroke [32] and coronary artery disease (CAD)
[33]. In the present study, we failed to replicate these
observations in IA patients from south India. Another
pro-inflammatory cytokine IL6 had been the point of
intense study by several investigators. Morgan et al.
(2006) first reported that IL6 promoter polymorphism
rs1800796 (−572C/G) and rs1800795 (−174G/C) are as-
sociated with IA in Caucasian population and 572C/
174C haplotype having a greater risk [10]. Subsequent
studies with these variants in Italian and Chinese popu-
lation had shown conflicting results [11–14]. While
rs1800796 and rs1800795 were not associated with IA
in Italian population [11], it was a conflict of allelic as-
sociations in Chinese population. In Han Chinese [12]
and west Chinese population [14], G allele proved to be
a risk allele, whereas in Cantonese population, C allele
turned out to be a risk allele for IA [13]. None of these
allelic associations for IL6 could be replicated in our
study population for IA. Observations from some of
these extensively investigated proinflammatory cyto-
kines remained inconclusive; therefore, we carried out a
meta-analysis with these SNPs by including the present
study. Meta-analysis with rs3212227 of IL12B and
rs16944 of IL1B did not show any association in both
fixed effect and random effect models, while with IL6
indicated tremendous heterogeneity between studies
which could be accounted to large variation in different
studies shown by opposite alleles being associated in
different world population. Therefore, conflicting allelic
association of IL6 needs to be carefully interpreted in
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comorbid factors that can influence IL6 production and
subsequently result in development of IA. These
ethnic-specific genetic associations are important to
understand the complex nature of the disease which
might help in modeling the gene-environment inter-
action. All these studies indicate that the cascade of
events in pro-inflammatory cytokine circuit is active,
but sequence of events in the circuit tends to differ in
different ethnicities in developing risk for IA.
None of the anti-inflammatory or pleiotropic cyto-
kines were found to be associated at allelic or genotypic
combinations in the present study with exception to
IL10. In IL10, the heterozygous genotypes of the two
tagged SNPs rs1800871 and rs1800872 were observed
to be associated with IA. IL10 is a potent anti-
inflammatory and immunomodulatory cytokine, exert-
ing major effects in the degree and quality of the
immune response. It is a potent suppressor of pro-
inflammatory cytokines such as IL1, IL6, IL12, TNFA,
and IFNG and inhibits the costimulatory activity of
macrophages for T cell and NK cell activation. It is
monoallelically expressed in CD4+ T cells. Evidences
suggest that the monoallelic expression pattern of IL10
is not due to parental imprinting, allelic exclusion, or
strong allelic bias, instead, due to stochastic regulation
mechanism, in which the probability to initiate allelic
transcription depends on the strength of TCR signaling
and subsequent capacity to overcome restrictions im-
posed by chromatin hypoacetylation. Allelic expression
data shows transcriptional independence between both
alleles [34]. This could possibly help us understand why
in an earlier study, IL10 was not found to express in IA
patients [18]. Monoallelic expression and stochastic
regulation of IL10 might help us understand the func-
tional implication of heterozygous genotype with IAs,
observed in the present study. The rs1800872 variant
has been reported to be a low-producer allele of the
IL10 gene [35]. A recent study have reported that ap-
proximately one third of the genes have the same allele
expressed more highly in all heterozygotes, suggesting
that their regulation is predominantly influenced by cis
elements in strong linkage disequilibrium with the
assayed exonic SNP. The remaining two thirds of the
genes have different alleles expressed more highly in
different heterozygotes, suggesting that their expression
differences are influenced by factors not in strong link-
age disequilibrium with the assayed exonic SNP [36].
Interestingly, stochastic monoallelic expression of IL10
has been reported which are transcriptionally inde-
pendent [34]. Based on these observations, one can
suggest that the pathologic modulation of cis- or the
trans-acting factors on the heterozygous genotypes
might result in the development of aneurysm.Conclusion
We conclude that genetic liability of anti-inflammatory
IL10 rs1800871 and rs1800872 variant in combination with
pro-inflammatory TNFA rs361525 and IFNG rs2069718
gene variant may promote pathogenesis of IA. The differ-
ential inflammatory response mediated by genetic variants
in cytokines could be a primary event, while inflammatory
response mediated by stochastic events of pre- or post-
traumatic stress or comorbid factors could further
augment the disease pathology. It has been reported that
locally secreted cytokines may tilt the regional balance of
matrix metalloproteinases (MMP) activity in favor of vas-
cular matrix degradation [37]. Therefore, chronic exposure
to pro-inflammatory cytokines TNFA and IFNG and sto-
chastic regulation of IL10 and TGFB in response to patho-
logic environment may support development of IA. The
implication and interaction of these genetic variants under
a specific environmental background will help us identify
the resultant phenotypic variation in the pathogenesis of
intracranial aneurysm. Identifying genetic risk factors for
inflammation might also help in understanding and ad-
dressing the post-traumatic complications following the
aneurismal rupture.
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